The biopharmaceutical industry is a fascinating and cyclical ecosystem. Despite the stiff economic headwinds currently blowing—funding slowdowns, debt, inflation, etc.—this is a time to feel bullish about the industry. Click here for more from Worldwide’s President and CEO Peter Benton.